What is Apixaban?

Category: Prescription Drugs

Most popular types: Eliquis

false

Apixaban is an anticoagulant. It is used to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation not related to a heart valve problem.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Prevent blood clotting 19 12
Atrial fibrillation 10 8
Blood clots in legs 2 1
Antiphospholipid antibody syndrome 1 0
Deep vein thrombosis 1 1

Show all 8 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
0
Mild
2
None
18

Commonly reported side effects and conditions associated with Apixaban

Side effect Patients
Bruising 1
Fatigue 1
Loss of sense of taste 1

Dosages

Based on patients currently taking Apixaban

Dosage Patients
5 mg twice daily 17
2.5 mg twice daily 4
5 mg daily 3
10 mg twice daily 2
10 mg daily 1

Why patients stopped taking Apixaban

Multiple reasons could be selected

Reason Patients
Change in health plan coverage 2
Course of treatment ended 2
Doctor's advice 2
Expense 2
Did not seem to work 1
See all 6 patients who've stopped taking Apixaban

Duration

Currently taking Apixaban

Duration Patients
1 - 6 months 3
6 months - 1 year 4
1 - 2 years 11
2 - 5 years 9

Stopped taking Apixaban

Duration Patients
Less than 1 month 1
1 - 6 months 3
6 months - 1 year 1
1 - 2 years 1
Adherence
Adherence Evaluations
Always 18
Usually 1
Sometimes 0
Never taken as prescribed 1
Burden
Burden Evaluations
Very hard to take 1
Somewhat hard to take 1
A little hard to take 3
Not at all hard to take 15
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 3
$50-99 1
$25-49 1
< $25 6
Not specified 9

What people switch to and from

Patients started taking Apixaban after stopping:

Treatment Patients
Warfarin (Coumadin) 6
Clopidogrel (Plavix) 3
Rivaroxaban (Xarelto) 2
Carvedilol (Coreg) 1
Lisinopril (Zestril) 1

Show all 7 treatments patients report switching from

Patients stopped taking Apixaban and switched to:

Treatment Patients
Rivaroxaban (Xarelto) 1
Warfarin (Coumadin) 1
Last updated:

2 patient evaluations for Apixaban

Aug 15, 2017 (Started Jul 07, 2017)

  • Effectiveness
    Major (for stroke)
  • Effectiveness
    Major (for Prevent blood clotting)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 10 mg Daily

  • 0 helpful marks

Jan 8, 2017 (Started Jan 15, 2017)

  • Effectiveness
    Major (for deep vein thrombosis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 10 mg Daily

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Apixaban